|
A First-in-Class Anti-Hypertensive Therapy
Synthetic peptides for the treatment of resistant hypertension and acute hypertensive crisis
Background:
Despite the number of available treatments, nearly one-third of the over 73 million patients with hypertension respond poorly to current treatment options. This presents a significant commercial opportunity for new therapies with novel mechanisms...
Published: 4/30/2025
|
Inventor(s): Wolfgang Dostmann, Brent Osborne, Thomas Moon
Keywords(s):
Category(s): Technology Classifications > Biomedical
|
